European Injectable Drug Delivery Market by Type (Device, Formulation), Therapeutic (Hormonal, Oncology), Usage Pattern (Curative Care, Immunization), Administration (Skin, Musculoskeletal), End User (Hospital, Home care Setting) - Forecast to 2020
The European injectable drug delivery market is expected to reach $207.3 billion by 2020 from $114.7 billion in 2015, growing at a CAGR of 12.6% from 2015 to 2020. The market is categorized on the basis of type, therapeutic application, usage pattern, mode of administration, end user, and region. The therapeutic application market is further segmented into autoimmune diseases, hormonal disorders, oncology, orphan diseases, and other therapeutic applications. The oncology segment is expected to witness the highest CAGR in the forecast period.
Factors such as rising incidences of chronic diseases, growth of the biologics market, demand of self-injection devices, and technological advancements, are driving the growth of the European injectable drug delivery market. In addition, Europe is emphasizing on innovation of formulations and improving the delivery of pharmaceuticals. For instance, in November 2012, COMPACT (Collaboration on the Optimization of Macromolecular Pharmaceutical Access to Cellular Targets), a public-private consortium funded by the Innovative Medicines Initiative (IMI), announced the launch of a €30 million ($38.5 million) project, which focuses on improving the delivery of biopharmaceuticals. The consortium would address the major bottlenecks in the development of novel innovative medicines based on biological macromolecules, such as proteins/peptides and oligonucleotides. Such investments are fueling the growth of the market.
Germany is expected to be the fastest-growing country in the European injectable drug delivery market. High growth in this market can be attributed to the increased demand for injectable insulin and self-injection devices, particularly pen injectors which are used in the treatment of diabetes.
Apart from comprehensive geographic and product analysis and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by industry players over the last three years. In addition, the company profiles comprise basic views on key players in the European injectable drug delivery market and product portfolios, developments, and strategies adopted by market players to maintain and increase their market shares in the near future. The above-mentioned market research data, current market size, and forecast of future trends will help key players and new entrants to make the necessary decisions regarding product offerings, geographical focus, change in strategic approach, R&D investments for innovations in products and technologies, and levels of output in order to remain successful.
Reasons to Buy the Report:
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms to garner a greater market share. Firms purchasing the report can use one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.
The report provides insights on the following pointers:
Factors such as rising incidences of chronic diseases, growth of the biologics market, demand of self-injection devices, and technological advancements, are driving the growth of the European injectable drug delivery market. In addition, Europe is emphasizing on innovation of formulations and improving the delivery of pharmaceuticals. For instance, in November 2012, COMPACT (Collaboration on the Optimization of Macromolecular Pharmaceutical Access to Cellular Targets), a public-private consortium funded by the Innovative Medicines Initiative (IMI), announced the launch of a €30 million ($38.5 million) project, which focuses on improving the delivery of biopharmaceuticals. The consortium would address the major bottlenecks in the development of novel innovative medicines based on biological macromolecules, such as proteins/peptides and oligonucleotides. Such investments are fueling the growth of the market.
Germany is expected to be the fastest-growing country in the European injectable drug delivery market. High growth in this market can be attributed to the increased demand for injectable insulin and self-injection devices, particularly pen injectors which are used in the treatment of diabetes.
Apart from comprehensive geographic and product analysis and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by industry players over the last three years. In addition, the company profiles comprise basic views on key players in the European injectable drug delivery market and product portfolios, developments, and strategies adopted by market players to maintain and increase their market shares in the near future. The above-mentioned market research data, current market size, and forecast of future trends will help key players and new entrants to make the necessary decisions regarding product offerings, geographical focus, change in strategic approach, R&D investments for innovations in products and technologies, and levels of output in order to remain successful.
Reasons to Buy the Report:
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms to garner a greater market share. Firms purchasing the report can use one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.
The report provides insights on the following pointers:
- Market Penetration: Comprehensive information on the product portfolios of the top players in the European injectable drug delivery market. The report analyzes this market by type, therapeutic application, usage pattern, mode of administration, end user, and region
- Product Development/Innovation: Detailed insights on upcoming technologies, R&D activities, and new product launches in the European injectable drug delivery market
- Competitive Assessment: In-depth assessment of market strategies, geographical and business segments, and product portfolios of leading players in the European injectable drug delivery market
- Market Development: Comprehensive information about lucrative markets. The report analyzes the market for various European injectable drug delivery across countries
- Market Diversification: Exhaustive information about new products and services, untapped geographies, recent developments, and investments in the European injectable drug delivery market
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 MARKET STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 MARKET SIZE ESTIMATION
2.2 MARKET BREAKDOWN AND DATA TRIANGULATION
2.3 KEY DATA FROM SECONDARY SOURCES
2.4 KEY DATA FROM PRIMARY SOURCES
2.5 ASSUMPTIONS FOR THE STUDY
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 EUROPEAN INJECTable DRUG DELIVERY MARKET, BY FORMULATION
4.2 EUROPEAN INJECTable DRUG DELIVERY MARKET, BY USAGE PATTERN
4.3 EUROPEAN INJECTable DRUG DELIVERY MARKET, BY END USER
4.4 EUROPEAN INJECTable DRUG DELIVERY MARKET, BY THERAPEUTIC APPLICATION
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET SEGMENTATION
5.2.1 BY TYPE
5.2.2 BY THERAPEUTIC APPLICATION
5.2.3 BY USAGE PATTERN
5.2.4 BY MODE OF ADMINISTRATION
5.2.5 BY END USER
5.2.6 BY REGION
5.3 MARKET DYNAMICS
5.4 DRIVERS
5.4.1 RISING PREVALENCE OF CHRONIC DISEASES
5.4.2 INCREASE IN DEMAND FOR SELF –INJECTION DEVICES
5.4.3 GROWTH OF THE BIOLOGICS MARKET
5.4.4 TECHNOLOGICAL ADVANCEMENTS
5.5 RESTRAINTS
5.5.1 NEEDLESTICK INJURIES AND INFECTIONS
5.5.2 RISE OF ALTERNATE MODE OF DRUG DELIVERY
5.6 OPPORTUNITIES
5.6.1 INCREASE IN DEMAND FOR BIOSIMILARS AND GENERIC INJECTABLES
5.6.1.1 Biosimilars
5.6.1.2 Generic injectables
5.6.2 CONTRACEPTIVE INJECTABLES
5.7 CHALLENGES
5.7.1 PRODUCT RECALL
5.7.2 REGULATORY HURDLES
5.7.3 STABILITY OF THE PRODUCT
5.7.4 STERILITY OF INJECTIONS
6 EUROPEAN INJECTABLE DRUG DELIVERY MARKET, BY TYPE
6.1 INTRODUCTION
6.2 DEVICES
6.2.1 CONVENTIONAL INJECTION DEVICES
6.2.1.1 By Material
6.2.1.1.1 Glass
6.2.1.1.2 Plastic
6.2.1.2 By Product
6.2.1.2.1 Fillable syringes
6.2.1.2.2 Prefilled syringes
6.2.1.3 By Usability
6.2.1.3.1 Reusable syringes
6.2.1.3.2 Disposable syringes
6.2.2 SELF-INJECTION DEVICES
6.2.2.1 Needle-free injectors
6.2.2.1.1 By product
6.2.2.1.1.1 Fillable needle-free injectors
6.2.2.1.1.2 Prefilled needle-free injectors
6.2.2.1.2 By technology
6.2.2.1.2.1 Jet-based needle-free injectors
6.2.2.1.2.2 Spring-based Needle-free injectors
6.2.2.1.2.3 Laser-powered needle-free injectors
6.2.2.1.2.4 Vibration-based needle-free injectors
6.2.2.1.3 By usability
6.2.2.1.3.1 Reusable needle-free injectors
6.2.2.1.3.2 Disposable needle-free injectors
6.2.2.2 Autoinjectors
6.2.2.2.1 By product
6.2.2.2.1.1 Fillable autoinjectors
6.2.2.2.1.2 Prefilled autoinjectors
6.2.2.2.2 By technology
6.2.2.2.2.1 Automated Autoinjectors
6.2.2.2.2.2 Manual Autoinjectors
6.2.2.2.3 By design
6.2.2.2.3.1 Standardized Autoinjectors
6.2.2.2.3.2 Customized Autoinjectors
6.2.2.2.4 By usability
6.2.2.2.4.1 Reusable autoinjectors
6.2.2.2.4.2 Disposable Autoinjectors
6.2.2.3 Pen injectors
6.2.2.3.1 By product
6.2.2.3.1.1 Single-chambered Pen Injectors
6.2.2.3.1.2 Dual-chambered Pen Injectors
6.2.2.3.2 By design
6.2.2.3.2.1 Standard Pen Injectors
6.2.2.3.2.2 Customized Pen Injectors
6.2.2.3.3 By usability
6.2.2.3.3.1 Reusable Pen Injectors
6.2.2.3.3.2 Disposable Pen Injectors
6.2.2.4 Wearable injectors
6.2.2.5 Other Devices
6.3 FORMULATIONS
6.3.1 CONVENTIONAL DRUG DELIVERY
6.3.1.1 SOLUTIONS
6.3.1.2 RECONSTITUTED/LYOPHILIZED FORMULATIONS
6.3.1.3 SUSPENSIONS
6.3.1.4 EMULSIONS
6.3.2 NOVEL DRUG DELIVERY FORMULATIONS
6.3.2.1 COLLOIDAL DISPERSIONS
6.3.2.1.1 LIPOSOMES
6.3.2.1.2 NIOSOMES
6.3.2.1.3 POLYMERIC/MIXED MICELLE
6.3.2.1.4 NANOPARTICLES
6.3.2.1.4.1 NANOSUSPENSIONS
6.3.2.1.4.2 NANOEMULSIONS/MICROEMULSIONS
6.3.2.1.4.3 SOLID-LIPID NANOPARTICLES
6.3.2.2 MICROPARTICLES
6.3.2.2.1 MICROSPHERES
6.3.2.2.2 MICROCAPSULES
6.3.3 LONG-ACTING INJECTION FORMULATIONS
7 EUROPEAN INJECTABLE DRUG DELIVERY MARKET, BY THERAPEUTIC APPLICATION
7.1 INTRODUCTION
7.2 AUTOIMMUNE DISEASES
7.2.1 RHEUMATOID ARTHRITIS
7.2.2 MULTIPLE SCLEROSIS
7.2.3 CROHN’S DISEASE
7.2.4 PSORIASIS
7.2.5 OTHER AUTOIMMUNE DISEASES
7.3 HORMONAL DISORDERS
7.3.1 DIABETES
7.3.2 ANEMIA
7.3.3 REPRODUCTIVE HEALTH DISEASE
7.3.4 ANTITHROMBOTIC/THROMBOLYTIC THERAPY
7.3.5 OSTEOPOROSIS
7.3.6 GROWTH HORMONE DEFICIENCY (GHD)
7.4 ORPHAN DISEASES
7.5 ONCOLOGY
7.6 OTHERS
7.6.1 PAIN MANAGEMENT
7.6.2 ALLERGY TREATMENT
7.6.3 AESTHETIC TREATMENT
7.6.4 HEPATITIS C
7.6.5 HEMOPHILIA
8 EUROPEAN INJECTABLE DRUG DELIVERY MARKET, BY USAGE PATTERN
8.1 INTRODUCTION
8.2 CURATIVE CARE
8.3 IMMUNIZATION
8.4 OTHERS (BLOOD TRANSFUSION AND BLOOD PRODUCTS AND CONTRACEPTIVES)
9 EUROPEAN INJECTABLE DRUG DELIVERY MARKET, BY MODE OF ADMINISTRATION
9.1 INTRODUCTION
9.2 SKIN
9.3 CIRCULATORY/MUSCULOSKELETAL
9.4 ORGANS
9.5 CENTRAL NERVOUS SYSTEM
10 EUROPEAN INJECTABLE DRUG DELIVERY MARKET, BY END USER
10.1 INTRODUCTION
10.2 HOSPITALS AND CLINICS
10.3 HOME CARE SETTINGS
10.4 RESEARCH LABORATORIES
10.5 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
10.6 OTHER END USERS
11 EUROPEAN INJECTABLE DRUG DELIVERY MARKET, BY COUNTRY
11.1 INTRODUCTION
11.1.1 GERMANY
11.1.2 FRANCE
11.1.3 U.K.
11.1.4 ITALY
11.1.5 SPAIN
11.1.6 REST OF EUROPE (ROE)
12 COMPETITIVE LANDSCAPE
12.1 OVERVIEW
12.2 MARKET SHARE ANALYSIS
12.3 COMPETITIVE SITUATIONS & TRENDS
12.3.1 NEW PRODUCT LAUNCHES
12.3.2 FDA APPROVALS
12.3.3 EXPANSIONS AND INVESTMENTS
12.3.4 ACQUISITIONS
12.3.5 COLLABORATIONS & AGREEMENTS
13 COMPANY PROFILES
(Overview, Financials, Products & Services, Strategy, & Developments)*
13.1 INTRODUCTION
13.2 BAXTER INTERNATIONAL, INC.
13.3 BECTON, DICKINSON AND COMPANY
13.4 GERRESHEIMER AG
13.5 PFIZER, INC.
13.6 SCHOTT AG
13.7 ALKERMES PLC.
13.8 ELI LILLY AND COMPANY
13.9 SANDOZ
13.10 TERUMO CORPORATION
13.11 TEVA PHARMACEUTICAL INDUSTRIES LTD.
*Details on Financials, Product & Services, Strategy, & Developments might not be captured in case of unlisted companies.
14 APPENDIX
14.1 INSIGHTS FROM INDUSTRY EXPERTS
14.2 DISCUSSION GUIDE
14.3 OTHER RECENT DEVELOPMENTS
14.4 AVAILABLE CUSTOMIZATIONS
14.5 RT: REAL-TIME MARKET INTELLIGENCE
14.6 RELATED REPORTS
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 MARKET STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 MARKET SIZE ESTIMATION
2.2 MARKET BREAKDOWN AND DATA TRIANGULATION
2.3 KEY DATA FROM SECONDARY SOURCES
2.4 KEY DATA FROM PRIMARY SOURCES
2.5 ASSUMPTIONS FOR THE STUDY
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 EUROPEAN INJECTable DRUG DELIVERY MARKET, BY FORMULATION
4.2 EUROPEAN INJECTable DRUG DELIVERY MARKET, BY USAGE PATTERN
4.3 EUROPEAN INJECTable DRUG DELIVERY MARKET, BY END USER
4.4 EUROPEAN INJECTable DRUG DELIVERY MARKET, BY THERAPEUTIC APPLICATION
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET SEGMENTATION
5.2.1 BY TYPE
5.2.2 BY THERAPEUTIC APPLICATION
5.2.3 BY USAGE PATTERN
5.2.4 BY MODE OF ADMINISTRATION
5.2.5 BY END USER
5.2.6 BY REGION
5.3 MARKET DYNAMICS
5.4 DRIVERS
5.4.1 RISING PREVALENCE OF CHRONIC DISEASES
5.4.2 INCREASE IN DEMAND FOR SELF –INJECTION DEVICES
5.4.3 GROWTH OF THE BIOLOGICS MARKET
5.4.4 TECHNOLOGICAL ADVANCEMENTS
5.5 RESTRAINTS
5.5.1 NEEDLESTICK INJURIES AND INFECTIONS
5.5.2 RISE OF ALTERNATE MODE OF DRUG DELIVERY
5.6 OPPORTUNITIES
5.6.1 INCREASE IN DEMAND FOR BIOSIMILARS AND GENERIC INJECTABLES
5.6.1.1 Biosimilars
5.6.1.2 Generic injectables
5.6.2 CONTRACEPTIVE INJECTABLES
5.7 CHALLENGES
5.7.1 PRODUCT RECALL
5.7.2 REGULATORY HURDLES
5.7.3 STABILITY OF THE PRODUCT
5.7.4 STERILITY OF INJECTIONS
6 EUROPEAN INJECTABLE DRUG DELIVERY MARKET, BY TYPE
6.1 INTRODUCTION
6.2 DEVICES
6.2.1 CONVENTIONAL INJECTION DEVICES
6.2.1.1 By Material
6.2.1.1.1 Glass
6.2.1.1.2 Plastic
6.2.1.2 By Product
6.2.1.2.1 Fillable syringes
6.2.1.2.2 Prefilled syringes
6.2.1.3 By Usability
6.2.1.3.1 Reusable syringes
6.2.1.3.2 Disposable syringes
6.2.2 SELF-INJECTION DEVICES
6.2.2.1 Needle-free injectors
6.2.2.1.1 By product
6.2.2.1.1.1 Fillable needle-free injectors
6.2.2.1.1.2 Prefilled needle-free injectors
6.2.2.1.2 By technology
6.2.2.1.2.1 Jet-based needle-free injectors
6.2.2.1.2.2 Spring-based Needle-free injectors
6.2.2.1.2.3 Laser-powered needle-free injectors
6.2.2.1.2.4 Vibration-based needle-free injectors
6.2.2.1.3 By usability
6.2.2.1.3.1 Reusable needle-free injectors
6.2.2.1.3.2 Disposable needle-free injectors
6.2.2.2 Autoinjectors
6.2.2.2.1 By product
6.2.2.2.1.1 Fillable autoinjectors
6.2.2.2.1.2 Prefilled autoinjectors
6.2.2.2.2 By technology
6.2.2.2.2.1 Automated Autoinjectors
6.2.2.2.2.2 Manual Autoinjectors
6.2.2.2.3 By design
6.2.2.2.3.1 Standardized Autoinjectors
6.2.2.2.3.2 Customized Autoinjectors
6.2.2.2.4 By usability
6.2.2.2.4.1 Reusable autoinjectors
6.2.2.2.4.2 Disposable Autoinjectors
6.2.2.3 Pen injectors
6.2.2.3.1 By product
6.2.2.3.1.1 Single-chambered Pen Injectors
6.2.2.3.1.2 Dual-chambered Pen Injectors
6.2.2.3.2 By design
6.2.2.3.2.1 Standard Pen Injectors
6.2.2.3.2.2 Customized Pen Injectors
6.2.2.3.3 By usability
6.2.2.3.3.1 Reusable Pen Injectors
6.2.2.3.3.2 Disposable Pen Injectors
6.2.2.4 Wearable injectors
6.2.2.5 Other Devices
6.3 FORMULATIONS
6.3.1 CONVENTIONAL DRUG DELIVERY
6.3.1.1 SOLUTIONS
6.3.1.2 RECONSTITUTED/LYOPHILIZED FORMULATIONS
6.3.1.3 SUSPENSIONS
6.3.1.4 EMULSIONS
6.3.2 NOVEL DRUG DELIVERY FORMULATIONS
6.3.2.1 COLLOIDAL DISPERSIONS
6.3.2.1.1 LIPOSOMES
6.3.2.1.2 NIOSOMES
6.3.2.1.3 POLYMERIC/MIXED MICELLE
6.3.2.1.4 NANOPARTICLES
6.3.2.1.4.1 NANOSUSPENSIONS
6.3.2.1.4.2 NANOEMULSIONS/MICROEMULSIONS
6.3.2.1.4.3 SOLID-LIPID NANOPARTICLES
6.3.2.2 MICROPARTICLES
6.3.2.2.1 MICROSPHERES
6.3.2.2.2 MICROCAPSULES
6.3.3 LONG-ACTING INJECTION FORMULATIONS
7 EUROPEAN INJECTABLE DRUG DELIVERY MARKET, BY THERAPEUTIC APPLICATION
7.1 INTRODUCTION
7.2 AUTOIMMUNE DISEASES
7.2.1 RHEUMATOID ARTHRITIS
7.2.2 MULTIPLE SCLEROSIS
7.2.3 CROHN’S DISEASE
7.2.4 PSORIASIS
7.2.5 OTHER AUTOIMMUNE DISEASES
7.3 HORMONAL DISORDERS
7.3.1 DIABETES
7.3.2 ANEMIA
7.3.3 REPRODUCTIVE HEALTH DISEASE
7.3.4 ANTITHROMBOTIC/THROMBOLYTIC THERAPY
7.3.5 OSTEOPOROSIS
7.3.6 GROWTH HORMONE DEFICIENCY (GHD)
7.4 ORPHAN DISEASES
7.5 ONCOLOGY
7.6 OTHERS
7.6.1 PAIN MANAGEMENT
7.6.2 ALLERGY TREATMENT
7.6.3 AESTHETIC TREATMENT
7.6.4 HEPATITIS C
7.6.5 HEMOPHILIA
8 EUROPEAN INJECTABLE DRUG DELIVERY MARKET, BY USAGE PATTERN
8.1 INTRODUCTION
8.2 CURATIVE CARE
8.3 IMMUNIZATION
8.4 OTHERS (BLOOD TRANSFUSION AND BLOOD PRODUCTS AND CONTRACEPTIVES)
9 EUROPEAN INJECTABLE DRUG DELIVERY MARKET, BY MODE OF ADMINISTRATION
9.1 INTRODUCTION
9.2 SKIN
9.3 CIRCULATORY/MUSCULOSKELETAL
9.4 ORGANS
9.5 CENTRAL NERVOUS SYSTEM
10 EUROPEAN INJECTABLE DRUG DELIVERY MARKET, BY END USER
10.1 INTRODUCTION
10.2 HOSPITALS AND CLINICS
10.3 HOME CARE SETTINGS
10.4 RESEARCH LABORATORIES
10.5 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
10.6 OTHER END USERS
11 EUROPEAN INJECTABLE DRUG DELIVERY MARKET, BY COUNTRY
11.1 INTRODUCTION
11.1.1 GERMANY
11.1.2 FRANCE
11.1.3 U.K.
11.1.4 ITALY
11.1.5 SPAIN
11.1.6 REST OF EUROPE (ROE)
12 COMPETITIVE LANDSCAPE
12.1 OVERVIEW
12.2 MARKET SHARE ANALYSIS
12.3 COMPETITIVE SITUATIONS & TRENDS
12.3.1 NEW PRODUCT LAUNCHES
12.3.2 FDA APPROVALS
12.3.3 EXPANSIONS AND INVESTMENTS
12.3.4 ACQUISITIONS
12.3.5 COLLABORATIONS & AGREEMENTS
13 COMPANY PROFILES
(Overview, Financials, Products & Services, Strategy, & Developments)*
13.1 INTRODUCTION
13.2 BAXTER INTERNATIONAL, INC.
13.3 BECTON, DICKINSON AND COMPANY
13.4 GERRESHEIMER AG
13.5 PFIZER, INC.
13.6 SCHOTT AG
13.7 ALKERMES PLC.
13.8 ELI LILLY AND COMPANY
13.9 SANDOZ
13.10 TERUMO CORPORATION
13.11 TEVA PHARMACEUTICAL INDUSTRIES LTD.
*Details on Financials, Product & Services, Strategy, & Developments might not be captured in case of unlisted companies.
14 APPENDIX
14.1 INSIGHTS FROM INDUSTRY EXPERTS
14.2 DISCUSSION GUIDE
14.3 OTHER RECENT DEVELOPMENTS
14.4 AVAILABLE CUSTOMIZATIONS
14.5 RT: REAL-TIME MARKET INTELLIGENCE
14.6 RELATED REPORTS
LIST OF TABLES
Table 1 INCREASE IN DEMAND FOR SELF-INJECTION DEVICES IS BOOSTING THE MARKET GROWTH
Table 2 NEEDLESTICK INJURIES AND INFECTIONS ARE RESTRAINING THE MARKET GROWTH
Table 3 INCREASE IN DEMAND OF BIOSIMILARS OFFERS AN ARRAY OF OPPORTUNITIES FOR THE MARKET
Table 4 PRODUCT RECALL POSE SIGNIFICANT CHALLENGES TO MARKET GROWTH
Table 5 EUROPE: INJECTable DRUG DELIVERY MARKET SIZE, BY TYPE, 2013–2020 ($MILLION)
Table 6 EUROPE: INJECTable DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2013–2020 ($MILLION)
Table 7 EUROPE: INJECTable DRUG DELIVERY DEVICES MARKET SIZE, BY TYPE, 2013–2020 ($MILLION)
Table 8 EUROPE: INJECTable DRUG DELIVERY DEVICES MARKET SIZE, BY TYPE, 2013–2020 (MILLION UNITS)
Table 9 EUROPE: INJECTable DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2013–2020 ($MILLION)
Table 10 EUROPE: INJECTable DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2013–2020 (MILLION UNITS)
Table 11 EUROPE: CONVENTIONAL INJECTION DEVICES MARKET SIZE, BY COUNTRY, 2013–2020 ($MILLION)
Table 12 EUROPE: CONVENTIONAL INJECTION DEVICES MARKET SIZE, BY COUNTRY, 2013–2020 (MILLION UNITS)
Table 13 EUROPE: CONVENTIONAL INJECTION DEVICES MARKET SIZE, BY MATERIAL, 2013–2020 ($MILLION)
Table 14 EUROPE: CONVENTIONAL INJECTION DEVICES MARKET SIZE, BY MATERIAL, 2013–2020 (MILLION UNITS)
Table 15 EUROPE: CONVENTIONAL GLASS INJECTION DEVICES MARKET SIZE, BY COUNTRY, 2013–2020 ($MILLION)
Table 16 EUROPE: CONVENTIONAL GLASS INJECTION DEVICES MARKET SIZE, BY COUNTRY, 2013–2020 (MILLION UNITS)
Table 17 EUROPE: CONVENTIONAL PLASTIC INJECTION DEVICES MARKET SIZE, BY COUNTRY, 2013–2020 ($MILLION)
Table 18 EUROPE: CONVENTIONAL PLASTIC INJECTION DEVICES MARKET SIZE, BY COUNTRY, 2013–2020 (MILLION UNITS)
Table 19 EUROPE: CONVENTIONAL INJECTION DEVICES MARKET SIZE, BY PRODUCT, 2013–2020 ($MILLION)
Table 20 EUROPE: CONVENTIONAL INJECTION DEVICES MARKET SIZE, BY PRODUCT, 2013–2020 (MILLION UNITS)
Table 21 EUROPE: CONVENTIONAL FILLABLE INJECTION DEVICES MARKET SIZE, BY COUNTRY, 2013–2020 ($MILLION)
Table 22 EUROPE: CONVENTIONAL FILLABLE INJECTION DEVICES MARKET SIZE, BY COUNTRY, 2013–2020 (MILLION UNITS)
Table 23 EUROPE: CONVENTIONAL PREFILLED INJECTION DEVICES MARKET SIZE, BY COUNTRY, 2013–2020 ($MILLION)
Table 24 EUROPE: CONVENTIONAL PREFILLED INJECTION DEVICES MARKET SIZE, BY COUNTRY, 2013–2020 (MILLION UNITS)
Table 25 EUROPE: CONVENTIONAL INJECTION DEVICES MARKET SIZE, BY USABILITY, 2013–2020 ($MILLION)
Table 26 EUROPE: CONVENTIONAL INJECTION DEVICES MARKET SIZE, BY USABILITY, 2013–2020 (MILLION UNITS)
Table 27 EUROPE: CONVENTIONAL REUSABLE INJECTION DEVICES MARKET SIZE, BY COUNTRY, 2013–2020 ($MILLION)
Table 28 EUROPE: CONVENTIONAL REUSABLE INJECTION DEVICES MARKET SIZE, BY COUNTRY, 2013–2020 (MILLION UNITS)
Table 29 EUROPE: CONVENTIONAL DISPOSABLE INJECTION DEVICES MARKET SIZE, BY COUNTRY, 2013–2020 ($MILLION)
Table 30 EUROPE: CONVENTIONAL DISPOSABLE INJECTION DEVICES MARKET SIZE, BY COUNTRY, 2013–2020 (MILLION UNITS)
Table 31 EUROPE: SELF-INJECTION DEVICES MARKET, BY TYPE, 2013–2020 ($MILLION)
Table 32 EUROPE: SELF-INJECTION DEVICES MARKET, BY TYPE, 2013–2020 (MILLION UNITS)
Table 33 EUROPE: SELF-INJECTION DEVICES MARKET SIZE, BY COUNTRY, 2013–2020 ($MILLION)
Table 34 EUROPE: SELF-INJECTION DEVICES MARKET SIZE, BY COUNTRY, 2013–2020 (MILLION UNITS)
Table 35 EUROPE: NEEDLE-FREE INJECTORS MARKET SIZE, BY COUNTRY, 2013–2020 ($MILLION)
Table 36 EUROPE: NEEDLE-FREE INJECTORS MARKET SIZE, BY COUNTRY, 2013–2020 (MILLION UNITS)
Table 37 EUROPE: NEEDLE-FREE INJECTORS MARKET SIZE, BY PRODUCT, 2013–2020 ($MILLION)
Table 38 EUROPE: NEEDLE-FREE INJECTORS MARKET SIZE, BY PRODUCT, 2013–2020 (MILLION UNITS)
Table 39 EUROPE: FILLABLE NEEDLE-FREE INJECTORS MARKET SIZE, BY COUNTRY, 2013–2020 ($MILLION)
Table 40 EUROPE: FILLABLE NEEDLE-FREE INJECTORS MARKET SIZE, BY COUNTRY, 2013–2020 (MILLION UNITS)
Table 41 EUROPE: PREFILLED NEEDLE-FREE INJECTORS MARKET SIZE, BY COUNTRY, 2013–2020 ($MILLION)
Table 42 EUROPE: PREFILLED NEEDLE-FREE INJECTORS MARKET SIZE, BY COUNTRY, 2013–2020 (MILLION UNITS)
Table 43 EUROPE: NEEDLE-FREE INJECTORS MARKET SIZE, BY TECHNOLOGY, 2013–2020 ($MILLION)
Table 44 EUROPE: NEEDLE-FREE INJECTORS MARKET SIZE, BY TECHNOLOGY, 2013–2020 (MILLION UNITS)
Table 45 EUROPE: JET-BASED NEEDLE-FREE INJECTORS MARKET SIZE, BY COUNTRY, 2013–2020 ($MILLION)
Table 46 EUROPE: JET-BASED NEEDLE-FREE INJECTORS MARKET SIZE, BY COUNTRY, 2013–2020 (MILLION UNITS)
Table 47 EUROPE: SPRING-BASED NEEDLE-FREE INJECTORS MARKET SIZE, BY COUNTRY, 2013–2020 ($MILLION)
Table 48 EUROPE: SPRING-BASED NEEDLE-FREE INJECTORS MARKET SIZE, BY COUNTRY, 2013–2020 (MILLION UNITS)
Table 49 EUROPE: LASER-POWERED NEEDLE-FREE INJECTORS MARKET SIZE, BY COUNTRY, 2013–2020 ($MILLION)
Table 50 EUROPE: LASER-POWERED NEEDLE-FREE INJECTORS MARKET, BY COUNTRY, 2013–2020 (MILLION UNITS)
Table 51 EUROPE: VIBRATION-BASED NEEDLE-FREE INJECTORS MARKET SIZE, BY COUNTRY, 2013–2020 ($MILLION)
Table 52 EUROPE: VIBRATION-BASED NEEDLE-FREE INJECTORS MARKET SIZE, BY COUNTRY, 2013–2020 (MILLION UNITS)
Table 53 EUROPE: NEEDLE-FREE INJECTORS MARKET SIZE, BY USABILITY, 2013–2020 ($MILLION)
Table 54 EUROPE: NEEDLE-FREE INJECTORS MARKET SIZE, BY USABILITY, 2013–2020 (MILLION UNITS)
Table 55 EUROPE: REUSABLE NEEDLE-FREE INJECTORS MARKET SIZE, BY COUNTRY, 2013–2020 ($MILLION)
Table 56 EUROPE: REUSABLE NEEDLE-FREE INJECTORS MARKET SIZE, BY COUNTRY, 2013–2020 (MILLION UNITS)
Table 57 EUROPE: DISPOSABLE NEEDLE-FREE INJECTORS MARKET SIZE, BY COUNTRY, 2013–2020 ($MILLION)
Table 58 EUROPE: DISPOSABLE NEEDLE-FREE INJECTORS MARKET SIZE, BY COUNTRY, 2013–2020 (MILLION UNITS)
Table 59 EUROPE: AUTOINJECTOR DEVICES MARKET SIZE, BY COUNTRY, 2013–2020 ($MILLION)
Table 60 EUROPE: AUTOINJECTOR DEVICES MARKET SIZE, BY COUNTRY, 2013–2020 (MILLION UNITS)
Table 61 EUROPE: AUTOINJECTOR DEVICES MARKET SIZE, BY PRODUCT, 2013–2020 ($MILLION)
Table 62 EUROPE: AUTOINJECTOR DEVICES MARKET SIZE, BY PRODUCT, 2013–2020 (MILLION UNITS)
Table 63 EUROPE: FILLABLE AUTOINJECTOR DEVICES MARKET SIZE, BY COUNTRY, 2013–2020 ($MILLION)
Table 64 EUROPE: FILLABLE AUTOINJECTOR DEVICES MARKET SIZE, BY COUNTRY, 2013–2020 (MILLION UNITS)
Table 65 EUROPE: PREFILLED AUTOINJECTOR DEVICES MARKET SIZE, BY COUNTRY, 2013–2020 ($MILLION)
Table 66 EUROPE: PREFILLED AUTOINJECTOR DEVICES MARKET SIZE, BY COUNTRY, 2013–2020 (MILLION UNITS)
Table 67 EUROPE: AUTOINJECTOR DEVICES MARKET SIZE, BY TECHNOLOGY, 2013–2020 ($MILLION)
Table 68 EUROPE: AUTOINJECTOR DEVICES MARKET SIZE, BY TECHNOLOGY, 2013–2020 (MILLION UNITS)
Table 69 EUROPE: AUTOMATED AUTOINJECTORS MARKET SIZE, BY COUNTRY, 2013–2020 ($MILLION)
Table 70 EUROPE: AUTOMATED AUTOINJECTORS MARKET SIZE, BY COUNTRY, 2013–2020 (MILLION UNITS)
Table 71 EUROPE: MANUAL AUTOINJECTORS MARKET SIZE, BY COUNTRY, 2013–2020 ($MILLION)
Table 72 EUROPE: MANUAL AUTOINJECTORS MARKET, BY COUNTRY, 2013–2020 (MILLION UNITS)
Table 73 EUROPE: AUTOINJECTORS MARKET SIZE, BY DESIGN, 2013–2020 ($MILLION)
Table 74 EUROPE: AUTOINJECTORS MARKET SIZE, BY DESIGN, 2013–2020 (MILLION UNITS)
Table 75 EUROPE: STANDARDIZED AUTOINJECTORS MARKET SIZE, BY COUNTRY, 2013–2020 ($MILLION)
Table 76 EUROPE: STANDARDIZED AUTOINJECTORS MARKET SIZE, BY COUNTRY, 2013–2020 (MILLION UNITS)
Table 77 EUROPE: CUSTOMIZED AUTOINJECTORS MARKET SIZE, BY COUNTRY, 2013–2020 ($MILLION)
Table 78 EUROPE: CUSTOMIZED AUTOINJECTORS MARKET SIZE, BY COUNTRY, 2013–2020 (MILLION UNITS)
Table 79 EUROPE: AUTOINJECTOR MARKET SIZE, BY USABILITY, 2013–2020 ($MILLION)
Table 80 EUROPE: AUTOINJECTORS MARKET SIZE, BY USABILITY, 2013–2020 (MILLION UNITS)
Table 81 EUROPE: REUSABLE AUTOINJECTORS MARKET SIZE, BY COUNTRY, 2013–2020 ($MILLION)
Table 82 EUROPE: REUSABLE AUTOINJECTORS MARKET SIZE, BY COUNTRY, 2013–2020 (MILLION UNITS)
Table 83 EUROPE: DISPOSABLE AUTOINJECTORS MARKET SIZE, BY COUNTRY, 2013–2020 ($MILLION)
Table 84 EUROPE: DISPOSABLE AUTOINJECTORS MARKET SIZE, BY COUNTRY, 2013–2020 (MILLION UNITS)
Table 85 EUROPE: PEN INJECTORS MARKET SIZE, BY COUNTRY, 2013–2020 ($MILLION)
Table 86 EUROPE: PEN INJECTORS MARKET SIZE, BY COUNTRY, 2013–2020 (MILLION UNITS)
Table 87 EUROPE: PEN INJECTORS MARKET SIZE, BY PRODUCT, 2013–2020 ($MILLION)
Table 88 EUROPE: PEN INJECTORS MARKET SIZE, BY PRODUCT, 2013–2020 (MILLION UNITS)
Table 89 EUROPE: SINGLE-CHAMBERED PEN INJECTORS MARKET SIZE, BY COUNTRY, 2013–2020 ($MILLION)
Table 90 EUROPE: SINGLE-CHAMBERED PEN INJECTORS MARKET SIZE, BY COUNTRY, 2013–2020 (MILLION UNITS)
Table 91 EUROPE: DUAL-CHAMBERED PEN INJECTORS MARKET SIZE, BY COUNTRY, 2013–2020 ($MILLION)
Table 92 EUROPE: DUAL-CHAMBERED PEN INJECTORS MARKET SIZE, BY COUNTRY, 2013–2020 (MILLION UNITS)
Table 93 EUROPE: PEN INJECTORS MARKET SIZE, BY DESIGN, 2013–2020 ($MILLION)
Table 94 EUROPE: PEN INJECTORS MARKET SIZE, BY DESIGN, 2013–2020 (MILLION UNITS)
Table 95 EUROPE: STANDARD PEN INJECTORS MARKET SIZE, BY COUNTRY, 2013–2020 ($MILLION)
Table 96 EUROPE: STANDARD PEN INJECTORS MARKET SIZE, BY COUNTRY, 2013–2020 (MILLION UNITS)
Table 97 EUROPE: CUSTOMIZED PEN INJECTORS MARKET SIZE, BY COUNTRY, 2013–2020 ($MILLION)
Table 98 EUROPE: CUSTOMIZED PEN INJECTORS MARKET, BY COUNTRY, 2013–2020 (MILLION UNITS)
Table 99 EUROPE: PEN INJECTOR MARKET SIZE, BY USABILITY, 2013–2020 ($MILLION)
Table 100 EUROPE: PEN INJECTORS MARKET SIZE, BY USABILITY, 2013–2020 (MILLION UNITS)
Table 101 EUROPE: REUSABLE PEN INJECTORS MARKET SIZE, BY COUNTRY, 2013–2020 ($MILLION)
Table 102 EUROPE: REUSABLE PEN INJECTORS MARKET SIZE, BY COUNTRY, 2013–2020 (MILLION UNITS)
Table 103 EUROPE: DISPOSABLE PEN INJECTORS MARKET SIZE, BY COUNTRY, 2013–2020 ($MILLION)
Table 104 EUROPE: DISPOSABLE PEN INJECTORS MARKET SIZE, BY COUNTRY, 2013–2020 (MILLION UNITS)
Table 105 EUROPE: WEARABLE INJECTORS MARKET SIZE, BY COUNTRY, 2013–2020 ($MILLION)
Table 106 EUROPE: WEARABLE INJECTORS MARKET SIZE, BY COUNTRY, 2013–2020 (MILLION UNITS)
Table 107 EUROPE: OTHER DEVICES MARKET SIZE, BY COUNTRY, 2013–2020 ($MILLION)
Table 108 EUROPE: OTHER DEVICES MARKET SIZE, BY COUNTRY, 2013–2020 (MILLION UNITS)
Table 109 EUROPE: INJECTable DRUG DELIVERY FORMULATIONS MARKET SIZE, BY TYPE, 2013–2020 ($MILLION)
Table 110 EUROPE: INJECTable DRUG DELIVERY FORMULATIONS MARKET SIZE, BY COUNTRY, 2013–2020 ($MILLION)
Table 111 EUROPE: CONVENTIONAL DRUG DELIVERY FORMULATIONS MARKET SIZE, BY TYPE, 2013–2020 ($MILLION)
Table 112 EUROPE: CONVENTIONAL DRUG DELIVERY FORMULATIONS MARKET SIZE, BY COUNTRY, 2013–2020 ($MILLION)
Table 113 EUROPE: SOLUTIONS MARKET SIZE, BY COUNTRY, 2013–2020 ($MILLION)
Table 114 EUROPE: RECONSTITUTED/LYOPHILIZED FORMULATIONS MARKET SIZE, BY COUNTRY, 2013–2020 ($MILLION)
Table 115 EUROPE: SUSPENSIONS MARKET SIZE, BY COUNTRY, 2013–2020 ($MILLION)
Table 116 EUROPE: EMULSION MARKET SIZE, BY COUNTRY, 2013–2020 ($MILLION)
Table 117 EUROPE: NOVEL DRUG DELIVERY FORMULATIONS MARKET SIZE, BY TYPE, 2013–2020 ($MILLION)
Table 118 EUROPE: NOVEL DRUG DELIVERY FORMULATIONS MARKET SIZE, BY COUNTRY, 2013–2020 ($MILLION)
Table 119 EUROPE: COLLOIDAL DISPERSION MARKET SIZE, BY TYPE, 2013–2020 ($MILLION)
Table 120 EUROPE: COLLOIDAL DISPERSION MARKET SIZE, BY COUNTRY, 2013–2020 ($MILLION)
Table 121 EUROPE: LIPOSOMES MARKET SIZE, BY COUNTRY, 2013–2020 ($MILLION)
Table 122 EUROPE: NIOSOMES MARKET SIZE, BY COUNTRY, 2013–2020 ($MILLION)
Table 123 EUROPE: POLYMERIC/MIXED MICELLES MARKET SIZE, BY COUNTRY, 2013–2020 ($MILLION)
Table 124 EUROPE: NANOPARTICLES MARKET SIZE, BY TYPE, 2013–2020 ($MILLION)
Table 125 EUROPE: NANOPARTICLES MARKET SIZE, BY COUNTRY, 2013–2020 ($MILLION)
Table 126 EUROPE: NANOSUSPENSIONS MARKET SIZE, BY COUNTRY, 2013–2020 ($MILLION)
Table 127 EUROPE: NANOEMULSIONS/MICROEMULSIONS MARKET SIZE, BY COUNTRY, 2013–2020 ($MILLION)
Table 128 EUROPE: SOLID-LIPID NANOPARTICLES MARKET SIZE, BY COUNTRY, 2013–2020 ($MILLION)
Table 129 EUROPE: MICROPARTICLES MARKET SIZE, BY TYPE, 2013–2020 ($MILLION)
Table 130 EUROPE: MICROPARTICLES MARKET SIZE, BY COUNTRY, 2013–2020 ($MILLION)
Table 131 EUROPE: MICROSPHERES MARKET SIZE, BY COUNTRY, 2013–2020 ($MILLION)
Table 132 EUROPE: MICROCAPSULES MARKET SIZE, BY COUNTRY, 2013–2020 ($MILLION)
Table 133 EUROPE: LONG-ACTING INJECTION FORMULATIONS MARKET SIZE, BY COUNTRY, 2013–2020 ($MILLION)
Table 134 EUROPE: INJECTable DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2013 – 2020 ($MILLION)
Table 135 EUROPE: INJECTable DRUG DELIVERY THERAPEUTIC APPLICATIONS MARKET SIZE, BY COUNTRY, 2013 – 2020 ($MILLION)
Table 136 EUROPE: AUTOIMMUNE DISEASES MARKET SIZE, BY INDICATION, 2013-2020 ($MILLION)
Table 137 EUROPE: AUTOIMMUNE DISEASES MARKET SIZE, BY COUNTRY, 2013-2020 ($MILLION)
Table 138 EUROPE: RHEUMATOID ARTHRITIS MARKET SIZE, BY COUNTRY, 2013-2020 ($MILLION)
Table 139 EUROPE: MULTIPLE SCLEROSIS MARKET SIZE, BY COUNTRY, 2013-2020 ($MILLION)
Table 140 EUROPE: CROHN’S DISEASE MARKET SIZE, BY COUNTRY, 2013-2020 ($MILLION)
Table 141 EUROPE: PSORIASIS MARKET SIZE, BY COUNTRY, 2013-2020 ($MILLION)
Table 142 EUROPE: OTHER AUTOIMMUNE DISEASES MARKET SIZE, BY COUNTRY, 2013-2020 ($MILLION)
Table 143 EUROPE: HORMONAL DISORDERS MARKET SIZE, BY INDICATION, 2013-2020 ($MILLION)
Table 144 EUROPE: HORMONAL DISORDERS MARKET SIZE, BY COUNTRY, 2013 -2020 ($MILLION)
Table 145 EUROPE: DIABETES MARKET SIZE, BY COUNTRY, 2013-2020 ($MILLION)
Table 146 EUROPE: ANEMIA MARKET SIZE, BY COUNTRY, 2013-2020 ($MILLION)
Table 147 EUROPE: REPRODUCTIVE HEALTH DISEASE MARKET SIZE, BY COUNTRY, 2013-2020 ($MILLION)
Table 148 EUROPE: ANTITHROMBOTIC/THROMBOLYTIC THERAPY MARKET SIZE, BY COUNTRY, 2013-2020 ($MILLION)
Table 149 EUROPE: OSTEOPOROSIS MARKET SIZE, BY COUNTRY, 2013-2020 ($MILLION)
Table 150 EUROPE: GROWTH HORMONE DEFICIENCY (GHD) MARKET SIZE, BY COUNTRY, 2013-2020 ($MILLION)
Table 151 EUROPE: ORPHAN DISEASES MARKET SIZE, BY COUNTRY, 2013-2020 ($MILLION)
Table 152 EUROPE: ONCOLOGY MARKET SIZE, BY COUNTRY, 2013-2020 ($MILLION)
Table 153 EUROPE: OTHER THERAPEUTIC APPLICATIONS MARKET SIZE, BY INDICATION, 2013-2020 ($MILLION)
Table 154 EUROPE: OTHER THERAPEUTIC APPLICATIONS MARKET SIZE, BY COUNTRY, 2013-2020 ($MILLION)
Table 155 EUROPE: PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2013-2020 ($MILLION)
Table 156 EUROPE: ALLERGY MANAGEMENT MARKET SIZE, BY COUNTRY, 2013-2020 ($MILLION)
Table 157 EUROPE: AESTHETIC TREATMENT MARKET SIZE, BY COUNTRY, 2013-2020 ($MILLION)
Table 158 EUROPE: HEPATITIS C MARKET SIZE, BY COUNTRY, 2013-2020 ($MILLION)
Table 159 EUROPE: HEMOPHILIA MARKET SIZE, BY COUNTRY, 2013-2020 ($MILLION)
Table 160 EUROPE: INJECTable DRUG DELIVERY MARKET SIZE, BY USAGE PATTERN, 2013 – 2020 ($MILLION)
Table 161 EUROPE: USAGE PATTERN MARKET SIZE, BY COUNTRY, 2013-2020 ($MILLION)
Table 162 EUROPE: CURATIVE CARE MARKET SIZE, BY COUNTRY, 2013-2020 ($MILLION)
Table 163 EUROPE: IMMUNIZATION MARKET SIZE, BY COUNTRY, 2013-2020 ($MILLION)
Table 164 EUROPE: OTHER USAGE PATTERNS MARKET SIZE, BY COUNTRY, 2013 – 2020 ($MILLION)
Table 165 EUROPE: INJECTable DRUG DELIVERY MARKET SIZE, BY MODE OF ADMINISTRATION, 2013 – 2020 ($MILLION)
Table 166 EUROPE: MODE OF ADMINISTRATION MARKET SIZE, BY COUNTRY, 2013-2020 ($MILLION)
Table 167 EUROPE: SKIN ADMINISTRATION MARKET SIZE, BY COUNTRY, 2013-2020 ($MILLION)
Table 168 EUROPE: CIRCULATORY/MUSCULOSKELETAL ADMINISTRATION MARKET SIZE, BY COUNTRY, 2013-2020 ($MILLION)
Table 169 EUROPE: ORGAN ADMINISTRATION MARKET SIZE, BY COUNTRY, 2013-2020 ($MILLION)
Table 170 EUROPE: CENTRAL NERVOUS SYSTEM ADMINISTRATION, BY COUNTRY, 2013-2020 ($MILLION)
Table 171 EUROPE: INJECTable DRUG DELIVERY MARKET SIZE, BY END USER, 2013-2020 ($MILLION)
Table 172 EUROPE: END USER MARKET SIZE, BY COUNTRY, 2013-2020 ($MILLION)
Table 173 EUROPE: HOSPITALS AND CLINICS MARKET SIZE, BY COUNTRY, 2013-2020 ($MILLION)
Table 174 EUROPE: HOME CARE SETTING MARKET SIZE, BY COUNTRY, 2013-2020 ($MILLION)
Table 175 EUROPE: RESEARCH LABORATORIES MARKET SIZE, BY COUNTRY, 2013-2020 ($MILLION)
Table 176 EUROPE: PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES MARKET SIZE, BY COUNTRY, 2013-2020 ($MILLION)
Table 177 EUROPE: OTHER END USERS MARKET SIZE, BY COUNTRY, 2013-2020 ($MILLION)
Table 178 GERMANY: INJECTable DRUG DELIVERY MARKET SIZE, BY TYPE, 2013-2020 ($MILLION)
Table 179 GERMANY: INJECTable DRUG DELIVERY MARKET SIZE, BY DEVICE, 2013-2020 ($MILLION)
Table 180 GERMANY: INJECTable DRUG DELIVERY MARKET SIZE, BY DEVICE, 2013–2020 (MILLION UNITS)
Table 181 GERMANY: INJECTable DRUG DELIVERY MARKET SIZE, BY FORMULATION, 2013–2020 ($MILLION)
Table 182 GERMANY: INJECTable DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2013–2020 ($MILLION)
Table 183 GERMANY: INJECTable DRUG DELIVERY MARKET SIZE, BY USAGE PATTERN, 2013–2020 ($MILLION)
Table 184 GERMANY: INJECTable DRUG DELIVERY MARKET SIZE, BY MODE OF ADMINISTRATION, 2013–2020 ($MILLION)
Table 185 GERMANY: INJECTable DRUG DELIVERY MARKET SIZE, BY END USER, 2013–2020 ($MILLION)
Table 186 FRANCE :INJECTable DRUG DELIVERY MARKET SIZE, BY TYPE, 2013–2020 ($MILLION)
Table 187 FRANCE :INJECTable DRUG DELIVERY MARKET SIZE, BY DEVICE, 2013 – 2020 ($MILLION)
Table 188 FRANCE: INJECTable DRUG DELIVERY MARKET SIZE, BY DEVICE, 2013 – 2020 (MILLION UNITS)
Table 189 FRANCE: INJECTable DRUG DELIVERY MARKET SIZE, BY FORMULATION, 2013-2020 ($MILLION)
Table 190 FRANCE: INJECTable DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2013–2020 ($MILLION)
Table 191 FRANCE: INJECTable DRUG DELIVERY MARKET SIZE, BY USAGE PATTERN, 2013–2020 ($MILLION)
Table 192 FRANCE: INJECTable DRUG DELIVERY MARKET SIZE, BY MODE OF ADMINISTRATION, 2013–2020 ($MILLION)
Table 193 FRANCE: INJECTable DRUG DELIVERY MARKET SIZE, BY END USER, 2013–2020 ($MILLION)
Table 194 U.K.: INJECTable DRUG DELIVERY MARKET SIZE, BY TYPE, 2013-2020 ($MILLION)
Table 195 U.K.: INJECTable DRUG DELIVERY MARKET SIZE, BY DEVICE, 2013 - 2020 ($MILLION)
Table 196 U.K.: INJECTable DRUG DELIVERY MARKET SIZE, BY DEVICE, 2013-2020 (MILLION UNITS)
Table 197 U.K.: INJECTable DRUG DELIVERY MARKET SIZE, BY FORMULATION, 2013-2020 ($MILLION)
Table 198 U.K.: INJECTable DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2013-2020 ($MILLION)
Table 199 U.K.: INJECTable DRUG DELIVERY MARKET SIZE, BY USAGE PATTERN, 2013–2020 ($MILLION)
Table 200 U.K.: INJECTable DRUG DELIVERY MARKET SIZE, BY MODE OF ADMINISTRATION, 2013–2020 ($MILLION)
Table 201 U.K.: INJECTable DRUG DELIVERY MARKET SIZE, BY END USER, 2013–2020 ($MILLION)
Table 202 ITALY: INJECTable DRUG DELIVERY MARKET SIZE, BY TYPE, 2013–2020 ($MILLION)
Table 203 ITALY: INJECTable DRUG DELIVERY MARKET SIZE, BY DEVICE, 2013–2020 ($MILLION)
Table 204 ITALY: INJECTable DRUG DELIVERY MARKET SIZE, BY DEVICE, 2013–2020 (MILLION UNITS)
Table 205 ITALY: INJECTable DRUG DELIVERY MARKET SIZE, BY FORMULATION, 2013–2020 ($MILLION)
Table 206 ITALY: INJECTable DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2013–2020 ($MILLION)
Table 207 ITALY: INJECTable DRUG DELIVERY MARKET SIZE, BY USAGE PATTERN, 2013–2020 ($MILLION)
Table 208 ITALY: INJECTable DRUG DELIVERY MARKET SIZE, BY MODE OF ADMINISTRATION, 2013–2020 ($MILLION)
Table 209 ITALY: INJECTable DRUG DELIVERY MARKET SIZE, BY END USER, 2013–2020 ($MILLION)
Table 210 SPAIN: INJECTable DRUG DELIVERY MARKET SIZE, BY TYPE, 2013–2020 ($MILLION)
Table 211 SPAIN: INJECTable DRUG DELIVERY MARKET SIZE, BY DEVICE, 2013–2020 ($MILLION)
Table 212 SPAIN: INJECTable DRUG DELIVERY MARKET SIZE, BY DEVICE, 2013–2020 (MILLION UNITS)
Table 213 SPAIN: INJECTable DRUG DELIVERY MARKET SIZE, BY FORMULATION, 2013-2020 ($MILLION)
Table 214 SPAIN: INJECTable DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2013–2020 ($MILLION)
Table 215 SPAIN: INJECTable DRUG DELIVERY MARKET SIZE, BY USAGE PATTERN, 2013–2020 ($MILLION)
Table 216 SPAIN: INJECTable DRUG DELIVERY MARKET SIZE, BY MODE OF ADMINISTRATION, 2013–2020 ($MILLION)
Table 217 SPAIN: INJECTable DRUG DELIVERY MARKET SIZE, BY END USER, 2013–2020 ($MILLION)
Table 218 ROE: INJECTable DRUG DELIVERY MARKET SIZE, BY TYPE, 2013–2020 ($MILLION)
Table 219 ROE: INJECTable DRUG DELIVERY MARKET SIZE, BY DEVICE, 2013–2020 ($MILLION)
Table 220 ROE: INJECTable DRUG DELIVERY MARKET SIZE, BY DEVICE, 2013–2020 (MILLION UNITS)
Table 221 ROE: INJECTable DRUG DELIVERY MARKET SIZE, BY FORMULATION, 2013-2020 ($MILLION)
Table 222 ROE: INJECTable DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2013–2020 ($MILLION)
Table 223 ROE: INJECTable DRUG DELIVERY MARKET SIZE, BY USAGE PATTERN, 2013–2020 ($MILLION)
Table 224 ROE: INJECTable DRUG DELIVERY MARKET SIZE, BY MODE OF ADMINISTRATION, 2013–2020 ($MILLION)
Table 225 ROE: INJECTable DRUG DELIVERY MARKET SIZE, BY END USER, 2013–2020 ($MILLION)
Table 226 NEW PRODUCT LAUNCHES (2012–2015)
Table 227 FDA APPROVALS (2012–2015)
Table 228 EXPANSIONS AND INVESTMENTS (2012–2015)
Table 229 ACQUISITIONS (2012–2015)
Table 230 COLLABORATIONS & AGREEMENTS (2012–2015)
Table 1 INCREASE IN DEMAND FOR SELF-INJECTION DEVICES IS BOOSTING THE MARKET GROWTH
Table 2 NEEDLESTICK INJURIES AND INFECTIONS ARE RESTRAINING THE MARKET GROWTH
Table 3 INCREASE IN DEMAND OF BIOSIMILARS OFFERS AN ARRAY OF OPPORTUNITIES FOR THE MARKET
Table 4 PRODUCT RECALL POSE SIGNIFICANT CHALLENGES TO MARKET GROWTH
Table 5 EUROPE: INJECTable DRUG DELIVERY MARKET SIZE, BY TYPE, 2013–2020 ($MILLION)
Table 6 EUROPE: INJECTable DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2013–2020 ($MILLION)
Table 7 EUROPE: INJECTable DRUG DELIVERY DEVICES MARKET SIZE, BY TYPE, 2013–2020 ($MILLION)
Table 8 EUROPE: INJECTable DRUG DELIVERY DEVICES MARKET SIZE, BY TYPE, 2013–2020 (MILLION UNITS)
Table 9 EUROPE: INJECTable DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2013–2020 ($MILLION)
Table 10 EUROPE: INJECTable DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2013–2020 (MILLION UNITS)
Table 11 EUROPE: CONVENTIONAL INJECTION DEVICES MARKET SIZE, BY COUNTRY, 2013–2020 ($MILLION)
Table 12 EUROPE: CONVENTIONAL INJECTION DEVICES MARKET SIZE, BY COUNTRY, 2013–2020 (MILLION UNITS)
Table 13 EUROPE: CONVENTIONAL INJECTION DEVICES MARKET SIZE, BY MATERIAL, 2013–2020 ($MILLION)
Table 14 EUROPE: CONVENTIONAL INJECTION DEVICES MARKET SIZE, BY MATERIAL, 2013–2020 (MILLION UNITS)
Table 15 EUROPE: CONVENTIONAL GLASS INJECTION DEVICES MARKET SIZE, BY COUNTRY, 2013–2020 ($MILLION)
Table 16 EUROPE: CONVENTIONAL GLASS INJECTION DEVICES MARKET SIZE, BY COUNTRY, 2013–2020 (MILLION UNITS)
Table 17 EUROPE: CONVENTIONAL PLASTIC INJECTION DEVICES MARKET SIZE, BY COUNTRY, 2013–2020 ($MILLION)
Table 18 EUROPE: CONVENTIONAL PLASTIC INJECTION DEVICES MARKET SIZE, BY COUNTRY, 2013–2020 (MILLION UNITS)
Table 19 EUROPE: CONVENTIONAL INJECTION DEVICES MARKET SIZE, BY PRODUCT, 2013–2020 ($MILLION)
Table 20 EUROPE: CONVENTIONAL INJECTION DEVICES MARKET SIZE, BY PRODUCT, 2013–2020 (MILLION UNITS)
Table 21 EUROPE: CONVENTIONAL FILLABLE INJECTION DEVICES MARKET SIZE, BY COUNTRY, 2013–2020 ($MILLION)
Table 22 EUROPE: CONVENTIONAL FILLABLE INJECTION DEVICES MARKET SIZE, BY COUNTRY, 2013–2020 (MILLION UNITS)
Table 23 EUROPE: CONVENTIONAL PREFILLED INJECTION DEVICES MARKET SIZE, BY COUNTRY, 2013–2020 ($MILLION)
Table 24 EUROPE: CONVENTIONAL PREFILLED INJECTION DEVICES MARKET SIZE, BY COUNTRY, 2013–2020 (MILLION UNITS)
Table 25 EUROPE: CONVENTIONAL INJECTION DEVICES MARKET SIZE, BY USABILITY, 2013–2020 ($MILLION)
Table 26 EUROPE: CONVENTIONAL INJECTION DEVICES MARKET SIZE, BY USABILITY, 2013–2020 (MILLION UNITS)
Table 27 EUROPE: CONVENTIONAL REUSABLE INJECTION DEVICES MARKET SIZE, BY COUNTRY, 2013–2020 ($MILLION)
Table 28 EUROPE: CONVENTIONAL REUSABLE INJECTION DEVICES MARKET SIZE, BY COUNTRY, 2013–2020 (MILLION UNITS)
Table 29 EUROPE: CONVENTIONAL DISPOSABLE INJECTION DEVICES MARKET SIZE, BY COUNTRY, 2013–2020 ($MILLION)
Table 30 EUROPE: CONVENTIONAL DISPOSABLE INJECTION DEVICES MARKET SIZE, BY COUNTRY, 2013–2020 (MILLION UNITS)
Table 31 EUROPE: SELF-INJECTION DEVICES MARKET, BY TYPE, 2013–2020 ($MILLION)
Table 32 EUROPE: SELF-INJECTION DEVICES MARKET, BY TYPE, 2013–2020 (MILLION UNITS)
Table 33 EUROPE: SELF-INJECTION DEVICES MARKET SIZE, BY COUNTRY, 2013–2020 ($MILLION)
Table 34 EUROPE: SELF-INJECTION DEVICES MARKET SIZE, BY COUNTRY, 2013–2020 (MILLION UNITS)
Table 35 EUROPE: NEEDLE-FREE INJECTORS MARKET SIZE, BY COUNTRY, 2013–2020 ($MILLION)
Table 36 EUROPE: NEEDLE-FREE INJECTORS MARKET SIZE, BY COUNTRY, 2013–2020 (MILLION UNITS)
Table 37 EUROPE: NEEDLE-FREE INJECTORS MARKET SIZE, BY PRODUCT, 2013–2020 ($MILLION)
Table 38 EUROPE: NEEDLE-FREE INJECTORS MARKET SIZE, BY PRODUCT, 2013–2020 (MILLION UNITS)
Table 39 EUROPE: FILLABLE NEEDLE-FREE INJECTORS MARKET SIZE, BY COUNTRY, 2013–2020 ($MILLION)
Table 40 EUROPE: FILLABLE NEEDLE-FREE INJECTORS MARKET SIZE, BY COUNTRY, 2013–2020 (MILLION UNITS)
Table 41 EUROPE: PREFILLED NEEDLE-FREE INJECTORS MARKET SIZE, BY COUNTRY, 2013–2020 ($MILLION)
Table 42 EUROPE: PREFILLED NEEDLE-FREE INJECTORS MARKET SIZE, BY COUNTRY, 2013–2020 (MILLION UNITS)
Table 43 EUROPE: NEEDLE-FREE INJECTORS MARKET SIZE, BY TECHNOLOGY, 2013–2020 ($MILLION)
Table 44 EUROPE: NEEDLE-FREE INJECTORS MARKET SIZE, BY TECHNOLOGY, 2013–2020 (MILLION UNITS)
Table 45 EUROPE: JET-BASED NEEDLE-FREE INJECTORS MARKET SIZE, BY COUNTRY, 2013–2020 ($MILLION)
Table 46 EUROPE: JET-BASED NEEDLE-FREE INJECTORS MARKET SIZE, BY COUNTRY, 2013–2020 (MILLION UNITS)
Table 47 EUROPE: SPRING-BASED NEEDLE-FREE INJECTORS MARKET SIZE, BY COUNTRY, 2013–2020 ($MILLION)
Table 48 EUROPE: SPRING-BASED NEEDLE-FREE INJECTORS MARKET SIZE, BY COUNTRY, 2013–2020 (MILLION UNITS)
Table 49 EUROPE: LASER-POWERED NEEDLE-FREE INJECTORS MARKET SIZE, BY COUNTRY, 2013–2020 ($MILLION)
Table 50 EUROPE: LASER-POWERED NEEDLE-FREE INJECTORS MARKET, BY COUNTRY, 2013–2020 (MILLION UNITS)
Table 51 EUROPE: VIBRATION-BASED NEEDLE-FREE INJECTORS MARKET SIZE, BY COUNTRY, 2013–2020 ($MILLION)
Table 52 EUROPE: VIBRATION-BASED NEEDLE-FREE INJECTORS MARKET SIZE, BY COUNTRY, 2013–2020 (MILLION UNITS)
Table 53 EUROPE: NEEDLE-FREE INJECTORS MARKET SIZE, BY USABILITY, 2013–2020 ($MILLION)
Table 54 EUROPE: NEEDLE-FREE INJECTORS MARKET SIZE, BY USABILITY, 2013–2020 (MILLION UNITS)
Table 55 EUROPE: REUSABLE NEEDLE-FREE INJECTORS MARKET SIZE, BY COUNTRY, 2013–2020 ($MILLION)
Table 56 EUROPE: REUSABLE NEEDLE-FREE INJECTORS MARKET SIZE, BY COUNTRY, 2013–2020 (MILLION UNITS)
Table 57 EUROPE: DISPOSABLE NEEDLE-FREE INJECTORS MARKET SIZE, BY COUNTRY, 2013–2020 ($MILLION)
Table 58 EUROPE: DISPOSABLE NEEDLE-FREE INJECTORS MARKET SIZE, BY COUNTRY, 2013–2020 (MILLION UNITS)
Table 59 EUROPE: AUTOINJECTOR DEVICES MARKET SIZE, BY COUNTRY, 2013–2020 ($MILLION)
Table 60 EUROPE: AUTOINJECTOR DEVICES MARKET SIZE, BY COUNTRY, 2013–2020 (MILLION UNITS)
Table 61 EUROPE: AUTOINJECTOR DEVICES MARKET SIZE, BY PRODUCT, 2013–2020 ($MILLION)
Table 62 EUROPE: AUTOINJECTOR DEVICES MARKET SIZE, BY PRODUCT, 2013–2020 (MILLION UNITS)
Table 63 EUROPE: FILLABLE AUTOINJECTOR DEVICES MARKET SIZE, BY COUNTRY, 2013–2020 ($MILLION)
Table 64 EUROPE: FILLABLE AUTOINJECTOR DEVICES MARKET SIZE, BY COUNTRY, 2013–2020 (MILLION UNITS)
Table 65 EUROPE: PREFILLED AUTOINJECTOR DEVICES MARKET SIZE, BY COUNTRY, 2013–2020 ($MILLION)
Table 66 EUROPE: PREFILLED AUTOINJECTOR DEVICES MARKET SIZE, BY COUNTRY, 2013–2020 (MILLION UNITS)
Table 67 EUROPE: AUTOINJECTOR DEVICES MARKET SIZE, BY TECHNOLOGY, 2013–2020 ($MILLION)
Table 68 EUROPE: AUTOINJECTOR DEVICES MARKET SIZE, BY TECHNOLOGY, 2013–2020 (MILLION UNITS)
Table 69 EUROPE: AUTOMATED AUTOINJECTORS MARKET SIZE, BY COUNTRY, 2013–2020 ($MILLION)
Table 70 EUROPE: AUTOMATED AUTOINJECTORS MARKET SIZE, BY COUNTRY, 2013–2020 (MILLION UNITS)
Table 71 EUROPE: MANUAL AUTOINJECTORS MARKET SIZE, BY COUNTRY, 2013–2020 ($MILLION)
Table 72 EUROPE: MANUAL AUTOINJECTORS MARKET, BY COUNTRY, 2013–2020 (MILLION UNITS)
Table 73 EUROPE: AUTOINJECTORS MARKET SIZE, BY DESIGN, 2013–2020 ($MILLION)
Table 74 EUROPE: AUTOINJECTORS MARKET SIZE, BY DESIGN, 2013–2020 (MILLION UNITS)
Table 75 EUROPE: STANDARDIZED AUTOINJECTORS MARKET SIZE, BY COUNTRY, 2013–2020 ($MILLION)
Table 76 EUROPE: STANDARDIZED AUTOINJECTORS MARKET SIZE, BY COUNTRY, 2013–2020 (MILLION UNITS)
Table 77 EUROPE: CUSTOMIZED AUTOINJECTORS MARKET SIZE, BY COUNTRY, 2013–2020 ($MILLION)
Table 78 EUROPE: CUSTOMIZED AUTOINJECTORS MARKET SIZE, BY COUNTRY, 2013–2020 (MILLION UNITS)
Table 79 EUROPE: AUTOINJECTOR MARKET SIZE, BY USABILITY, 2013–2020 ($MILLION)
Table 80 EUROPE: AUTOINJECTORS MARKET SIZE, BY USABILITY, 2013–2020 (MILLION UNITS)
Table 81 EUROPE: REUSABLE AUTOINJECTORS MARKET SIZE, BY COUNTRY, 2013–2020 ($MILLION)
Table 82 EUROPE: REUSABLE AUTOINJECTORS MARKET SIZE, BY COUNTRY, 2013–2020 (MILLION UNITS)
Table 83 EUROPE: DISPOSABLE AUTOINJECTORS MARKET SIZE, BY COUNTRY, 2013–2020 ($MILLION)
Table 84 EUROPE: DISPOSABLE AUTOINJECTORS MARKET SIZE, BY COUNTRY, 2013–2020 (MILLION UNITS)
Table 85 EUROPE: PEN INJECTORS MARKET SIZE, BY COUNTRY, 2013–2020 ($MILLION)
Table 86 EUROPE: PEN INJECTORS MARKET SIZE, BY COUNTRY, 2013–2020 (MILLION UNITS)
Table 87 EUROPE: PEN INJECTORS MARKET SIZE, BY PRODUCT, 2013–2020 ($MILLION)
Table 88 EUROPE: PEN INJECTORS MARKET SIZE, BY PRODUCT, 2013–2020 (MILLION UNITS)
Table 89 EUROPE: SINGLE-CHAMBERED PEN INJECTORS MARKET SIZE, BY COUNTRY, 2013–2020 ($MILLION)
Table 90 EUROPE: SINGLE-CHAMBERED PEN INJECTORS MARKET SIZE, BY COUNTRY, 2013–2020 (MILLION UNITS)
Table 91 EUROPE: DUAL-CHAMBERED PEN INJECTORS MARKET SIZE, BY COUNTRY, 2013–2020 ($MILLION)
Table 92 EUROPE: DUAL-CHAMBERED PEN INJECTORS MARKET SIZE, BY COUNTRY, 2013–2020 (MILLION UNITS)
Table 93 EUROPE: PEN INJECTORS MARKET SIZE, BY DESIGN, 2013–2020 ($MILLION)
Table 94 EUROPE: PEN INJECTORS MARKET SIZE, BY DESIGN, 2013–2020 (MILLION UNITS)
Table 95 EUROPE: STANDARD PEN INJECTORS MARKET SIZE, BY COUNTRY, 2013–2020 ($MILLION)
Table 96 EUROPE: STANDARD PEN INJECTORS MARKET SIZE, BY COUNTRY, 2013–2020 (MILLION UNITS)
Table 97 EUROPE: CUSTOMIZED PEN INJECTORS MARKET SIZE, BY COUNTRY, 2013–2020 ($MILLION)
Table 98 EUROPE: CUSTOMIZED PEN INJECTORS MARKET, BY COUNTRY, 2013–2020 (MILLION UNITS)
Table 99 EUROPE: PEN INJECTOR MARKET SIZE, BY USABILITY, 2013–2020 ($MILLION)
Table 100 EUROPE: PEN INJECTORS MARKET SIZE, BY USABILITY, 2013–2020 (MILLION UNITS)
Table 101 EUROPE: REUSABLE PEN INJECTORS MARKET SIZE, BY COUNTRY, 2013–2020 ($MILLION)
Table 102 EUROPE: REUSABLE PEN INJECTORS MARKET SIZE, BY COUNTRY, 2013–2020 (MILLION UNITS)
Table 103 EUROPE: DISPOSABLE PEN INJECTORS MARKET SIZE, BY COUNTRY, 2013–2020 ($MILLION)
Table 104 EUROPE: DISPOSABLE PEN INJECTORS MARKET SIZE, BY COUNTRY, 2013–2020 (MILLION UNITS)
Table 105 EUROPE: WEARABLE INJECTORS MARKET SIZE, BY COUNTRY, 2013–2020 ($MILLION)
Table 106 EUROPE: WEARABLE INJECTORS MARKET SIZE, BY COUNTRY, 2013–2020 (MILLION UNITS)
Table 107 EUROPE: OTHER DEVICES MARKET SIZE, BY COUNTRY, 2013–2020 ($MILLION)
Table 108 EUROPE: OTHER DEVICES MARKET SIZE, BY COUNTRY, 2013–2020 (MILLION UNITS)
Table 109 EUROPE: INJECTable DRUG DELIVERY FORMULATIONS MARKET SIZE, BY TYPE, 2013–2020 ($MILLION)
Table 110 EUROPE: INJECTable DRUG DELIVERY FORMULATIONS MARKET SIZE, BY COUNTRY, 2013–2020 ($MILLION)
Table 111 EUROPE: CONVENTIONAL DRUG DELIVERY FORMULATIONS MARKET SIZE, BY TYPE, 2013–2020 ($MILLION)
Table 112 EUROPE: CONVENTIONAL DRUG DELIVERY FORMULATIONS MARKET SIZE, BY COUNTRY, 2013–2020 ($MILLION)
Table 113 EUROPE: SOLUTIONS MARKET SIZE, BY COUNTRY, 2013–2020 ($MILLION)
Table 114 EUROPE: RECONSTITUTED/LYOPHILIZED FORMULATIONS MARKET SIZE, BY COUNTRY, 2013–2020 ($MILLION)
Table 115 EUROPE: SUSPENSIONS MARKET SIZE, BY COUNTRY, 2013–2020 ($MILLION)
Table 116 EUROPE: EMULSION MARKET SIZE, BY COUNTRY, 2013–2020 ($MILLION)
Table 117 EUROPE: NOVEL DRUG DELIVERY FORMULATIONS MARKET SIZE, BY TYPE, 2013–2020 ($MILLION)
Table 118 EUROPE: NOVEL DRUG DELIVERY FORMULATIONS MARKET SIZE, BY COUNTRY, 2013–2020 ($MILLION)
Table 119 EUROPE: COLLOIDAL DISPERSION MARKET SIZE, BY TYPE, 2013–2020 ($MILLION)
Table 120 EUROPE: COLLOIDAL DISPERSION MARKET SIZE, BY COUNTRY, 2013–2020 ($MILLION)
Table 121 EUROPE: LIPOSOMES MARKET SIZE, BY COUNTRY, 2013–2020 ($MILLION)
Table 122 EUROPE: NIOSOMES MARKET SIZE, BY COUNTRY, 2013–2020 ($MILLION)
Table 123 EUROPE: POLYMERIC/MIXED MICELLES MARKET SIZE, BY COUNTRY, 2013–2020 ($MILLION)
Table 124 EUROPE: NANOPARTICLES MARKET SIZE, BY TYPE, 2013–2020 ($MILLION)
Table 125 EUROPE: NANOPARTICLES MARKET SIZE, BY COUNTRY, 2013–2020 ($MILLION)
Table 126 EUROPE: NANOSUSPENSIONS MARKET SIZE, BY COUNTRY, 2013–2020 ($MILLION)
Table 127 EUROPE: NANOEMULSIONS/MICROEMULSIONS MARKET SIZE, BY COUNTRY, 2013–2020 ($MILLION)
Table 128 EUROPE: SOLID-LIPID NANOPARTICLES MARKET SIZE, BY COUNTRY, 2013–2020 ($MILLION)
Table 129 EUROPE: MICROPARTICLES MARKET SIZE, BY TYPE, 2013–2020 ($MILLION)
Table 130 EUROPE: MICROPARTICLES MARKET SIZE, BY COUNTRY, 2013–2020 ($MILLION)
Table 131 EUROPE: MICROSPHERES MARKET SIZE, BY COUNTRY, 2013–2020 ($MILLION)
Table 132 EUROPE: MICROCAPSULES MARKET SIZE, BY COUNTRY, 2013–2020 ($MILLION)
Table 133 EUROPE: LONG-ACTING INJECTION FORMULATIONS MARKET SIZE, BY COUNTRY, 2013–2020 ($MILLION)
Table 134 EUROPE: INJECTable DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2013 – 2020 ($MILLION)
Table 135 EUROPE: INJECTable DRUG DELIVERY THERAPEUTIC APPLICATIONS MARKET SIZE, BY COUNTRY, 2013 – 2020 ($MILLION)
Table 136 EUROPE: AUTOIMMUNE DISEASES MARKET SIZE, BY INDICATION, 2013-2020 ($MILLION)
Table 137 EUROPE: AUTOIMMUNE DISEASES MARKET SIZE, BY COUNTRY, 2013-2020 ($MILLION)
Table 138 EUROPE: RHEUMATOID ARTHRITIS MARKET SIZE, BY COUNTRY, 2013-2020 ($MILLION)
Table 139 EUROPE: MULTIPLE SCLEROSIS MARKET SIZE, BY COUNTRY, 2013-2020 ($MILLION)
Table 140 EUROPE: CROHN’S DISEASE MARKET SIZE, BY COUNTRY, 2013-2020 ($MILLION)
Table 141 EUROPE: PSORIASIS MARKET SIZE, BY COUNTRY, 2013-2020 ($MILLION)
Table 142 EUROPE: OTHER AUTOIMMUNE DISEASES MARKET SIZE, BY COUNTRY, 2013-2020 ($MILLION)
Table 143 EUROPE: HORMONAL DISORDERS MARKET SIZE, BY INDICATION, 2013-2020 ($MILLION)
Table 144 EUROPE: HORMONAL DISORDERS MARKET SIZE, BY COUNTRY, 2013 -2020 ($MILLION)
Table 145 EUROPE: DIABETES MARKET SIZE, BY COUNTRY, 2013-2020 ($MILLION)
Table 146 EUROPE: ANEMIA MARKET SIZE, BY COUNTRY, 2013-2020 ($MILLION)
Table 147 EUROPE: REPRODUCTIVE HEALTH DISEASE MARKET SIZE, BY COUNTRY, 2013-2020 ($MILLION)
Table 148 EUROPE: ANTITHROMBOTIC/THROMBOLYTIC THERAPY MARKET SIZE, BY COUNTRY, 2013-2020 ($MILLION)
Table 149 EUROPE: OSTEOPOROSIS MARKET SIZE, BY COUNTRY, 2013-2020 ($MILLION)
Table 150 EUROPE: GROWTH HORMONE DEFICIENCY (GHD) MARKET SIZE, BY COUNTRY, 2013-2020 ($MILLION)
Table 151 EUROPE: ORPHAN DISEASES MARKET SIZE, BY COUNTRY, 2013-2020 ($MILLION)
Table 152 EUROPE: ONCOLOGY MARKET SIZE, BY COUNTRY, 2013-2020 ($MILLION)
Table 153 EUROPE: OTHER THERAPEUTIC APPLICATIONS MARKET SIZE, BY INDICATION, 2013-2020 ($MILLION)
Table 154 EUROPE: OTHER THERAPEUTIC APPLICATIONS MARKET SIZE, BY COUNTRY, 2013-2020 ($MILLION)
Table 155 EUROPE: PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2013-2020 ($MILLION)
Table 156 EUROPE: ALLERGY MANAGEMENT MARKET SIZE, BY COUNTRY, 2013-2020 ($MILLION)
Table 157 EUROPE: AESTHETIC TREATMENT MARKET SIZE, BY COUNTRY, 2013-2020 ($MILLION)
Table 158 EUROPE: HEPATITIS C MARKET SIZE, BY COUNTRY, 2013-2020 ($MILLION)
Table 159 EUROPE: HEMOPHILIA MARKET SIZE, BY COUNTRY, 2013-2020 ($MILLION)
Table 160 EUROPE: INJECTable DRUG DELIVERY MARKET SIZE, BY USAGE PATTERN, 2013 – 2020 ($MILLION)
Table 161 EUROPE: USAGE PATTERN MARKET SIZE, BY COUNTRY, 2013-2020 ($MILLION)
Table 162 EUROPE: CURATIVE CARE MARKET SIZE, BY COUNTRY, 2013-2020 ($MILLION)
Table 163 EUROPE: IMMUNIZATION MARKET SIZE, BY COUNTRY, 2013-2020 ($MILLION)
Table 164 EUROPE: OTHER USAGE PATTERNS MARKET SIZE, BY COUNTRY, 2013 – 2020 ($MILLION)
Table 165 EUROPE: INJECTable DRUG DELIVERY MARKET SIZE, BY MODE OF ADMINISTRATION, 2013 – 2020 ($MILLION)
Table 166 EUROPE: MODE OF ADMINISTRATION MARKET SIZE, BY COUNTRY, 2013-2020 ($MILLION)
Table 167 EUROPE: SKIN ADMINISTRATION MARKET SIZE, BY COUNTRY, 2013-2020 ($MILLION)
Table 168 EUROPE: CIRCULATORY/MUSCULOSKELETAL ADMINISTRATION MARKET SIZE, BY COUNTRY, 2013-2020 ($MILLION)
Table 169 EUROPE: ORGAN ADMINISTRATION MARKET SIZE, BY COUNTRY, 2013-2020 ($MILLION)
Table 170 EUROPE: CENTRAL NERVOUS SYSTEM ADMINISTRATION, BY COUNTRY, 2013-2020 ($MILLION)
Table 171 EUROPE: INJECTable DRUG DELIVERY MARKET SIZE, BY END USER, 2013-2020 ($MILLION)
Table 172 EUROPE: END USER MARKET SIZE, BY COUNTRY, 2013-2020 ($MILLION)
Table 173 EUROPE: HOSPITALS AND CLINICS MARKET SIZE, BY COUNTRY, 2013-2020 ($MILLION)
Table 174 EUROPE: HOME CARE SETTING MARKET SIZE, BY COUNTRY, 2013-2020 ($MILLION)
Table 175 EUROPE: RESEARCH LABORATORIES MARKET SIZE, BY COUNTRY, 2013-2020 ($MILLION)
Table 176 EUROPE: PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES MARKET SIZE, BY COUNTRY, 2013-2020 ($MILLION)
Table 177 EUROPE: OTHER END USERS MARKET SIZE, BY COUNTRY, 2013-2020 ($MILLION)
Table 178 GERMANY: INJECTable DRUG DELIVERY MARKET SIZE, BY TYPE, 2013-2020 ($MILLION)
Table 179 GERMANY: INJECTable DRUG DELIVERY MARKET SIZE, BY DEVICE, 2013-2020 ($MILLION)
Table 180 GERMANY: INJECTable DRUG DELIVERY MARKET SIZE, BY DEVICE, 2013–2020 (MILLION UNITS)
Table 181 GERMANY: INJECTable DRUG DELIVERY MARKET SIZE, BY FORMULATION, 2013–2020 ($MILLION)
Table 182 GERMANY: INJECTable DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2013–2020 ($MILLION)
Table 183 GERMANY: INJECTable DRUG DELIVERY MARKET SIZE, BY USAGE PATTERN, 2013–2020 ($MILLION)
Table 184 GERMANY: INJECTable DRUG DELIVERY MARKET SIZE, BY MODE OF ADMINISTRATION, 2013–2020 ($MILLION)
Table 185 GERMANY: INJECTable DRUG DELIVERY MARKET SIZE, BY END USER, 2013–2020 ($MILLION)
Table 186 FRANCE :INJECTable DRUG DELIVERY MARKET SIZE, BY TYPE, 2013–2020 ($MILLION)
Table 187 FRANCE :INJECTable DRUG DELIVERY MARKET SIZE, BY DEVICE, 2013 – 2020 ($MILLION)
Table 188 FRANCE: INJECTable DRUG DELIVERY MARKET SIZE, BY DEVICE, 2013 – 2020 (MILLION UNITS)
Table 189 FRANCE: INJECTable DRUG DELIVERY MARKET SIZE, BY FORMULATION, 2013-2020 ($MILLION)
Table 190 FRANCE: INJECTable DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2013–2020 ($MILLION)
Table 191 FRANCE: INJECTable DRUG DELIVERY MARKET SIZE, BY USAGE PATTERN, 2013–2020 ($MILLION)
Table 192 FRANCE: INJECTable DRUG DELIVERY MARKET SIZE, BY MODE OF ADMINISTRATION, 2013–2020 ($MILLION)
Table 193 FRANCE: INJECTable DRUG DELIVERY MARKET SIZE, BY END USER, 2013–2020 ($MILLION)
Table 194 U.K.: INJECTable DRUG DELIVERY MARKET SIZE, BY TYPE, 2013-2020 ($MILLION)
Table 195 U.K.: INJECTable DRUG DELIVERY MARKET SIZE, BY DEVICE, 2013 - 2020 ($MILLION)
Table 196 U.K.: INJECTable DRUG DELIVERY MARKET SIZE, BY DEVICE, 2013-2020 (MILLION UNITS)
Table 197 U.K.: INJECTable DRUG DELIVERY MARKET SIZE, BY FORMULATION, 2013-2020 ($MILLION)
Table 198 U.K.: INJECTable DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2013-2020 ($MILLION)
Table 199 U.K.: INJECTable DRUG DELIVERY MARKET SIZE, BY USAGE PATTERN, 2013–2020 ($MILLION)
Table 200 U.K.: INJECTable DRUG DELIVERY MARKET SIZE, BY MODE OF ADMINISTRATION, 2013–2020 ($MILLION)
Table 201 U.K.: INJECTable DRUG DELIVERY MARKET SIZE, BY END USER, 2013–2020 ($MILLION)
Table 202 ITALY: INJECTable DRUG DELIVERY MARKET SIZE, BY TYPE, 2013–2020 ($MILLION)
Table 203 ITALY: INJECTable DRUG DELIVERY MARKET SIZE, BY DEVICE, 2013–2020 ($MILLION)
Table 204 ITALY: INJECTable DRUG DELIVERY MARKET SIZE, BY DEVICE, 2013–2020 (MILLION UNITS)
Table 205 ITALY: INJECTable DRUG DELIVERY MARKET SIZE, BY FORMULATION, 2013–2020 ($MILLION)
Table 206 ITALY: INJECTable DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2013–2020 ($MILLION)
Table 207 ITALY: INJECTable DRUG DELIVERY MARKET SIZE, BY USAGE PATTERN, 2013–2020 ($MILLION)
Table 208 ITALY: INJECTable DRUG DELIVERY MARKET SIZE, BY MODE OF ADMINISTRATION, 2013–2020 ($MILLION)
Table 209 ITALY: INJECTable DRUG DELIVERY MARKET SIZE, BY END USER, 2013–2020 ($MILLION)
Table 210 SPAIN: INJECTable DRUG DELIVERY MARKET SIZE, BY TYPE, 2013–2020 ($MILLION)
Table 211 SPAIN: INJECTable DRUG DELIVERY MARKET SIZE, BY DEVICE, 2013–2020 ($MILLION)
Table 212 SPAIN: INJECTable DRUG DELIVERY MARKET SIZE, BY DEVICE, 2013–2020 (MILLION UNITS)
Table 213 SPAIN: INJECTable DRUG DELIVERY MARKET SIZE, BY FORMULATION, 2013-2020 ($MILLION)
Table 214 SPAIN: INJECTable DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2013–2020 ($MILLION)
Table 215 SPAIN: INJECTable DRUG DELIVERY MARKET SIZE, BY USAGE PATTERN, 2013–2020 ($MILLION)
Table 216 SPAIN: INJECTable DRUG DELIVERY MARKET SIZE, BY MODE OF ADMINISTRATION, 2013–2020 ($MILLION)
Table 217 SPAIN: INJECTable DRUG DELIVERY MARKET SIZE, BY END USER, 2013–2020 ($MILLION)
Table 218 ROE: INJECTable DRUG DELIVERY MARKET SIZE, BY TYPE, 2013–2020 ($MILLION)
Table 219 ROE: INJECTable DRUG DELIVERY MARKET SIZE, BY DEVICE, 2013–2020 ($MILLION)
Table 220 ROE: INJECTable DRUG DELIVERY MARKET SIZE, BY DEVICE, 2013–2020 (MILLION UNITS)
Table 221 ROE: INJECTable DRUG DELIVERY MARKET SIZE, BY FORMULATION, 2013-2020 ($MILLION)
Table 222 ROE: INJECTable DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2013–2020 ($MILLION)
Table 223 ROE: INJECTable DRUG DELIVERY MARKET SIZE, BY USAGE PATTERN, 2013–2020 ($MILLION)
Table 224 ROE: INJECTable DRUG DELIVERY MARKET SIZE, BY MODE OF ADMINISTRATION, 2013–2020 ($MILLION)
Table 225 ROE: INJECTable DRUG DELIVERY MARKET SIZE, BY END USER, 2013–2020 ($MILLION)
Table 226 NEW PRODUCT LAUNCHES (2012–2015)
Table 227 FDA APPROVALS (2012–2015)
Table 228 EXPANSIONS AND INVESTMENTS (2012–2015)
Table 229 ACQUISITIONS (2012–2015)
Table 230 COLLABORATIONS & AGREEMENTS (2012–2015)
LIST OF FIGURES
Figure 1 RESEARCH DESIGN
Figure 2 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
Figure 3 MARKET SIZE ESTIMATION: TOP-DOWN APPROACH
Figure 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE AND DESIGNATION
Figure 5 DATA TRIANGULATION METHODOLOGY
Figure 6 EUROPEAN INJECTable DRUG DELIVERY MARKET SNAPSHOT, BY FORMULATION (2015 VS. 2020)
Figure 7 EUROPEAN INJECTable DRUG DELIVERY MARKET, BY DEVICES (2015-2020): SELF-INJECTION DEVICES TO WITNESS HIGHEST GROWTH RATE
Figure 8 HOSPITALS/CLINICS FORM THE LARGEST END-USER SEGMENT IN 2014
Figure 9 EUROPEAN INJECTable DRUG DELIVERY MARKET, BY THERAPEUTIC APPLICATION (2015-2020): HORMONAL DISORDERS SEGMENT DOMINATES MARKET
Figure 10 EUROPEAN INJECTable DRUG DELIVERY FORMULATIONS MARKET TO GROW AT THE HIGHEST CAGR FROM 2015 TO 2020
Figure 11 THE CURATIVE CARE SEGMENT TO WITNESS THE HIGHEST GROWTH RATE IN THE FORECAST PERIOD
Figure 12 HOME CARE SETTINGS SEGMENT TO ACCOUNT FOR THE LARGEST SHARE IN 2015
Figure 13 HORMONAL DISORDERS SEGMENT TO ACCOUNT FOR THE LARGEST SHARE OF THE MARKET IN 2015
Figure 14 INJECTable DRUG DELIVERY MARKET SEGMENTATION, BY TYPE
Figure 15 INJECTable DRUG DELIVERY MARKET SEGMENTATION, BY THERAPEUTIC APPLICATION
Figure 16 INJECTable DRUG DELIVERY MARKET SEGMENTATION, BY USAGE PATTERN
Figure 17 INJECTable DRUG DELIVERY MARKET SEGMENTATION, BY MODE OF ADMINISTRATION
Figure 18 INJECTable DRUG DELIVERY MARKET SEGMENTATION, BY END USER
Figure 19 INJECTable DRUG DELIVERY MARKET SEGMENTATION, BY REGION
Figure 20 RISING PREVALENCE OF CHRONIC DISEASES POPULATION WILL DRIVE THE MARKET GROWTH
Figure 21 EUROPE: INJECTable DRUG DELIVERY MARKET, BY THERAPEUTIC APPLICATION, 2013 – 2020 ($MILLION)
Figure 22 THERAPEUTIC APPLICATIONS: GERMANY TO SHOW HIGHEST GROWTH
Figure 23 EUROPEAN INJECTable DRUG DELIVERY MARKET, BY USAGE PATTERN: CURATIVE CARE TO HOLD LARGEST SHARE
Figure 24 EUROPE: INJECTable DRUG DELIVERY MARKET, BY MODE OF ADMINISTRATION: SKIN SEGMENT TO SHOW HIGHEST GROWTH
Figure 25 EUROPE: INJECTable DRUG DELIVERY MARKET, BY END USER
Figure 26 EUROPE: EUROPEAN INJECTable DRUG DELIVERY MARKET, BY END USER: HOSPITALS/CLINICS TO HOLD LARGEST SHARE
Figure 27 EUROPE: FORMULATIONS MARKET SNAPSHOT
Figure 28 ROE: SELF-INJECTION DEVICES MARKET SNAPSHOT
Figure 29 KEY PLAYERS ADOPTED ORGANIC GROWTH STRATEGIES BETWEEN 2012 & 2015
Figure 30 GLOBAL INJECTable DRUG DELIVERY MARKET SHARE, BY KEY PLAYER (2014)
Figure 31 MARKET EVOLUTION FRAMEWORK: PARTNERSHIPS, AGREEMENTS AND COLLABORATIONS, & EXPANSIONS ARE FUELING MARKET GROWTH, 2014 &2015
Figure 32 BATTLE FOR MARKET SHARE: NEW PRODUCT LAUNCHES WAS THE KEY STRATEGY LEADING PLAYERS FOLLOWED, 2013
Figure 33 PRODUCT BENCHMARKING FOR TOP 5 PLAYERS
Figure 34 BAXTER INTERNATIONAL, INC.: COMPANY SNAPSHOT
Figure 35 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT
Figure 36 GERRESHEIMER AG: COMPANY SNAPSHOT
Figure 37 PFIZER, INC.: COMPANY SNAPSHOT
Figure 38 SCHOTT AG: COMPANY SNAPSHOT
Figure 39 ALKERMES PLC: COMPANY SNAPSHOT
Figure 40 ELI LILLY AND COMPANY: COMPANY SNAPSHOT
Figure 41 SANDOZ: COMPANY SNAPSHOT
Figure 42 TERUMO CORPORATION: COMPANY SNAPSHOT
Figure 43 TEVA PHARMACEUTICAL INDUSTRIES LTD.: COMPANY SNAPSHOT
Figure 1 RESEARCH DESIGN
Figure 2 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
Figure 3 MARKET SIZE ESTIMATION: TOP-DOWN APPROACH
Figure 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE AND DESIGNATION
Figure 5 DATA TRIANGULATION METHODOLOGY
Figure 6 EUROPEAN INJECTable DRUG DELIVERY MARKET SNAPSHOT, BY FORMULATION (2015 VS. 2020)
Figure 7 EUROPEAN INJECTable DRUG DELIVERY MARKET, BY DEVICES (2015-2020): SELF-INJECTION DEVICES TO WITNESS HIGHEST GROWTH RATE
Figure 8 HOSPITALS/CLINICS FORM THE LARGEST END-USER SEGMENT IN 2014
Figure 9 EUROPEAN INJECTable DRUG DELIVERY MARKET, BY THERAPEUTIC APPLICATION (2015-2020): HORMONAL DISORDERS SEGMENT DOMINATES MARKET
Figure 10 EUROPEAN INJECTable DRUG DELIVERY FORMULATIONS MARKET TO GROW AT THE HIGHEST CAGR FROM 2015 TO 2020
Figure 11 THE CURATIVE CARE SEGMENT TO WITNESS THE HIGHEST GROWTH RATE IN THE FORECAST PERIOD
Figure 12 HOME CARE SETTINGS SEGMENT TO ACCOUNT FOR THE LARGEST SHARE IN 2015
Figure 13 HORMONAL DISORDERS SEGMENT TO ACCOUNT FOR THE LARGEST SHARE OF THE MARKET IN 2015
Figure 14 INJECTable DRUG DELIVERY MARKET SEGMENTATION, BY TYPE
Figure 15 INJECTable DRUG DELIVERY MARKET SEGMENTATION, BY THERAPEUTIC APPLICATION
Figure 16 INJECTable DRUG DELIVERY MARKET SEGMENTATION, BY USAGE PATTERN
Figure 17 INJECTable DRUG DELIVERY MARKET SEGMENTATION, BY MODE OF ADMINISTRATION
Figure 18 INJECTable DRUG DELIVERY MARKET SEGMENTATION, BY END USER
Figure 19 INJECTable DRUG DELIVERY MARKET SEGMENTATION, BY REGION
Figure 20 RISING PREVALENCE OF CHRONIC DISEASES POPULATION WILL DRIVE THE MARKET GROWTH
Figure 21 EUROPE: INJECTable DRUG DELIVERY MARKET, BY THERAPEUTIC APPLICATION, 2013 – 2020 ($MILLION)
Figure 22 THERAPEUTIC APPLICATIONS: GERMANY TO SHOW HIGHEST GROWTH
Figure 23 EUROPEAN INJECTable DRUG DELIVERY MARKET, BY USAGE PATTERN: CURATIVE CARE TO HOLD LARGEST SHARE
Figure 24 EUROPE: INJECTable DRUG DELIVERY MARKET, BY MODE OF ADMINISTRATION: SKIN SEGMENT TO SHOW HIGHEST GROWTH
Figure 25 EUROPE: INJECTable DRUG DELIVERY MARKET, BY END USER
Figure 26 EUROPE: EUROPEAN INJECTable DRUG DELIVERY MARKET, BY END USER: HOSPITALS/CLINICS TO HOLD LARGEST SHARE
Figure 27 EUROPE: FORMULATIONS MARKET SNAPSHOT
Figure 28 ROE: SELF-INJECTION DEVICES MARKET SNAPSHOT
Figure 29 KEY PLAYERS ADOPTED ORGANIC GROWTH STRATEGIES BETWEEN 2012 & 2015
Figure 30 GLOBAL INJECTable DRUG DELIVERY MARKET SHARE, BY KEY PLAYER (2014)
Figure 31 MARKET EVOLUTION FRAMEWORK: PARTNERSHIPS, AGREEMENTS AND COLLABORATIONS, & EXPANSIONS ARE FUELING MARKET GROWTH, 2014 &2015
Figure 32 BATTLE FOR MARKET SHARE: NEW PRODUCT LAUNCHES WAS THE KEY STRATEGY LEADING PLAYERS FOLLOWED, 2013
Figure 33 PRODUCT BENCHMARKING FOR TOP 5 PLAYERS
Figure 34 BAXTER INTERNATIONAL, INC.: COMPANY SNAPSHOT
Figure 35 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT
Figure 36 GERRESHEIMER AG: COMPANY SNAPSHOT
Figure 37 PFIZER, INC.: COMPANY SNAPSHOT
Figure 38 SCHOTT AG: COMPANY SNAPSHOT
Figure 39 ALKERMES PLC: COMPANY SNAPSHOT
Figure 40 ELI LILLY AND COMPANY: COMPANY SNAPSHOT
Figure 41 SANDOZ: COMPANY SNAPSHOT
Figure 42 TERUMO CORPORATION: COMPANY SNAPSHOT
Figure 43 TEVA PHARMACEUTICAL INDUSTRIES LTD.: COMPANY SNAPSHOT
